Yearly Archives - 2021

TerraCom (ASX:TER) mine investigated by ASIC: ASX 0.1% lower at noon

30 Mar 2021 - The ASX rose at the open but started to fall soon after. It's now tracking 0.1% lower at noon. The S&P/ASX 200 index is 8 points down at 6,792. On the futures market the SPI is 5 points lower. TerraCom (ASX:TER) confirmed today that their Blair Athol Coal Mine in Queensland was attended by investigators from the Australian Securities and Investments Commission (ASIC) yesterday.

Read more...

TerraCom (ASX:TER) mine investigated by ASIC: ASX 0.1% lower at noon

30 Mar 2021 - The ASX rose at the open but started to fall soon after. It's now tracking 0.1% lower at noon. The S&P/ASX 200 index is 8 points down at 6,792. On the futures market the SPI is 5 points lower. TerraCom (ASX:TER) confirmed today that their Blair Athol Coal Mine in Queensland was attended by investigators from the Australian Securities and Investments Commission (ASIC) yesterday.

Read more...

Brisbane enters three-day lockdown: ASX poised to open higher

30 Mar 2021 - The ASX looks set to open higher this morning as the Dow ended the day slightly up. Greater Brisbane has entered its first full day in lockdown. The move comes after a Covid-19 cluster involving the highly contagious UK strain was discovered involving seven people. Infratil (ASX:IFT) has approved the on-market acquisition of $20 million of Infratil shares on behalf of certain Morrison & Co executives and Morrison & Co.

Read more...

Market failed to gain momentum despite strong open: ASX closed 0.4% lower

29 Mar 2021 - Mid morning trade saw a drop for the ASX and it failed to recover. At the closing bell the S&P/ASX 200 index closed 25 points lower, or 0.4 per cent lower to finish at 6,800. Treasury Wine Estates (ASX:TWE) acknowledges the release by China’s Ministry of Commerce of the final determination in its anti-dumping and countervailing investigations into certain Australian wine exports into China.

Read more...

Immutep (ASX:IMM) LAG-3 validated in Bristol Myers Squibb trial

29 Mar 2021 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt talks about the Bristol Myers Squibb trial evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo (nivolumab) in patients with previously untreated metastatic or unresectable melanoma, meeting its primary endpoint of progression-free survival and what it means for Immutep.

Read more...

XTEK (ASX:XTE) 1H21 results & outlook

29 Mar 2021 - XTEK Limited (ASX:XTE) Managing Director Phillipe Odouard talks 1H21 results, discussing the company's expanded operational capacity to meet demand for its high-value proprietary solutions in a favourable market environment for domestic and global defence industries.

Read more...